We have been working towards building a clearer picture about the true burden of AD and have commissioned new research to uncover the cost of living with AD in the European Union (EU), both financially and emotionally. You can read the full paper here, but we’ve put together a top-line overview for you below.
Research has shown that the overall cost of moderate-to-severe AD is considerably higher in people with uncontrolled symptoms, or more severe AD.2,3
These are direct costs that you pay towards medical treatment, which may be the 'obvious' costs you first think of when it comes to AD. Examples include:
These are the more subtle costs that aren’t associated with your medical treatment. People living with moderate-to-severe AD can spend up to €462 every year on personal non-medical costs.4 Examples of personal non-medical costs include:
Living with AD can have an impact on your wellbeing and productivity. Naturally, flares don’t always come at convenient times, and so it’s likely that you’ll have faced some indirect costs – for example:
A study in the Netherlands showed that people living with uncontrolled moderate-to-severe AD had much higher rates of work productivity losses compared to those with controlled moderate or severe AD.2
One of the hardest things to measure is the impact AD can have on your wellbeing and happiness, and overall quality of life, whether you suffer from AD yourself, or care for someone who does.
A study in Spain found that quality of life was linked to both disease severity and performance levels at work or school,6 which could lead to financial impacts as well.
Examples of the impact AD might have on your life:
So, how much is your AD really costing you? Potentially, a lot more than you thought. If you’ve found this summary helpful, you can read the full paper below.Read the whitepaper
If your current treatment isn’t effectively managing your symptoms and AD is significantly impacting your daily activities, ability to work, or mental wellbeing, your AD may be uncontrolled. Speak to your dermatologist about a long-term plan to try and take control of your AD.
Discussing treatments with your doctor can feel daunting, but we've got the information you need to feel confident in your appointments.Discover more
Feeling lost in a sea of terminology? Our glossary can help you feel confident when you discuss your AD.Expand your vocabulary
Feeling like you've tried everything to manage your AD? Don't lose hope. We've got the tips, tools and information you need to get closer to control.Go to Managing AD
Augustin M, Misery L, Kobyletzki LV, et al. Unveiling the true costs and societal impacts of moderate-to-severe atopic dermatitis in Europe. J Eur Acad Dermatol Venereol, 2022. 36(S7): p. 3-16.
Ariens, L.F.N., et al., Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment. Acta Derm Venereol, 2019. 99(9): p. 762-768.
Sircras-Mainar A, Navarro-Artieda R, Carrascosa Carrillo JM. Economic Impact of Atopic Dermatitis in Adults: A Population-Based Study. Actas Dermosifiliogr 2018. 109: p. 35-46.
Launois R et al. Importance of out-of-pocket costs for adult patients with atopic dermatitis in France. JEur Acad Dermatol Venereol, 2019. 33(10): p. 1921-1927.
Sciattella P et al. The burden of atopic dermatitis in adults in Italy. G Ital Dermatol Venereol, 2020. 155(1): p. 19-23.
Torrelo A et al. Atopic dermatitis: Impact on quality of life and patients' attitudes toward its management. Eur J Dermatol, 2012. 22(1): p. 97-105.